Thromb Haemost 1968; 20(03/04): 327-335
DOI: 10.1055/s-0038-1651275
Originalarbeiten – Original Articles – Travaux Originaux
Schattauer GmbH

Immune Reactions of Human Blood Platelets[*]

III. Inhibition of Immune Reactions by Sulfhydryl Reagents
Ch Mueller-Eckhardt
1   Theodor Kocher Institute, University of Berne
,
E. F Lüscher
1   Theodor Kocher Institute, University of Berne
› Author Affiliations
Further Information

Publication History

Publication Date:
27 June 2018 (online)

Preview

Summary

The effects of the SH-inhibitors monoiodoacetate (MIA) and N-ethylmaleimide (NEM) on washed human blood platelets and on reactions of the platelets with immune complexes and antiplatelet antisera were studied. The following results were obtained:

1. In the concentration range from 0.01 to 1 mM, only MIA in the highest concentration had a direct effect on platelets, discernible by a small but significant release of adenine nucleotides.

2. The reaction of human platelets with heterologous anti-platelet antisera, heat aggregated human gammaglobulin, and gammaglobulin-coated latex particles was inhibited by MIA in concentrations of 0.1 mM and by NEM in concentrations of 1 mM, and higher.

3. The SH-inhibitors tested exerted their influence on the platelet and not on the immune agents.

4. L-cysteine was unable to reverse the effect of the SH-inhibitors on platelets. If added at room temperature in equimolar amounts to MIA and NEM 10 min prior to their contact with platelets, it abolished the effect of NEM, but not of MIA.

5. The inhibition by MIA and NEM of platelet reactions with a variety of immune agents is comparable to the impairment of thrombin-induced viscous metamorphosis by SH-blockers. The obtained results do not support the assumption that immune agents and thrombin react with different, SH-group-containing substrates on the platelet surface.

* Supported by grants from the “Kommission zur Förderung der Eiweißforschung an der Universität Bern”, the “Schweizerischer Nationalfond zur Förderung der wissenschaftlichen Forschung”, and by the Department of Internal Medicine, University of Gießen, Germany.